A new drug for pancreatic cancer may significantly improve survival time, with some reports suggesting it could nearly double or double survival rates for some patients. The drug's effectiveness is based on the results of a trial, although details of the study's findings and the drug's availability vary. The potential impact of the drug on pancreatic cancer treatment is being described as a major development, but its accessibility to patients remains uncertain.